Literature DB >> 8634376

Cerebral emboli and cognitive outcome after cardiac surgery.

D A Stump1, A T Rogers, J W Hammon, S P Newman.   

Abstract

There have been major advancements in cardiac surgery over the past two decades, with a concomitant decrease in mortality and major morbidity. However, several recent studies have demonstrated that cardiac surgery poses significant risk for negative neurologic and neuropsychologic outcome. Although very few patients die as a result of cardiac surgery, more than two thirds of the patients demonstrate evidence of neuropsychologic dysfunction postoperatively. The mechanisms contributing to post-cardiopulmonary bypass neuropsychologic deficits are uncertain. However, two major interrelated etiologic factors, hypoperfusion and emboli, are suggested as probable culprits. It is important to define the relationship between these two putative mechanisms and postoperative neuropsychologic outcome in order to either prevent the problem or treat the effects of emboli or hypoperfusion. For example, if embolism is the cause of the deficits, increasing cerebral perfusion would deliver more emboli and increase the amount of severity of injury. Conversely, if hypoperfusion is the cause of the injury, then decreasing brain blood flow would increase the likelihood of injury. If both are important, their relative significance must be established, then one prevented and the effects of the other treated. This report discusses the methodology for detecting cerebral emboli during cardiac surgery. The incidence and severity of neuropsychologic deficits after cardiac surgery are discussed, as well as emboli in relation to composition and time of occurrence and their effect on neuropsychologic outcome.

Entities:  

Mesh:

Year:  1996        PMID: 8634376     DOI: 10.1016/s1053-0770(96)80186-8

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  21 in total

1.  [Retransfusion of autologous blood].

Authors:  E Hansen
Journal:  Anaesthesist       Date:  2002-05       Impact factor: 1.041

2.  Blood temperature management and gaseous microemboli creation: an in-vitro analysis.

Authors:  Joseph Sleep; Ingrid Syhre; Ed Evans
Journal:  J Extra Corpor Technol       Date:  2010-09

3.  Gaseous microemboli and the influence of microporous membrane oxygenators.

Authors:  Heinz-H Weitkemper; Bernd Oppermann; Andreas Spilker; Hermann-J Knobl; Reiner Körfer
Journal:  J Extra Corpor Technol       Date:  2005-09

Review 4.  From trash to leucocytes: what are we filtering and why?

Authors:  Simon J Mitchell
Journal:  J Extra Corpor Technol       Date:  2006-03

5.  In vitro evaluation of the air separation ability of four cardiovascular manufacturer extracorporeal circuit designs.

Authors:  Timothy A Dickinson; Jeffrey B Riley; Jeffrey C Crowley; Paul M Zabetakis
Journal:  J Extra Corpor Technol       Date:  2006-09

6.  Cannulae and cell saver design: do they make a difference?

Authors:  David A Stump
Journal:  J Extra Corpor Technol       Date:  2007-12

7.  Incidence of Cerebral Microemboli in Single-Dose vs. Multidose Cardioplegia in Adult Cardiac Surgery.

Authors:  Laith Mukdad; William Toppen; Yas Sanaiha; Aditya Mantha; Stephanie Bland; Richard Shemin; Peyman Benharash
Journal:  J Extra Corpor Technol       Date:  2018-09

Review 8.  A risk-benefit assessment of aprotinin in cardiac surgical procedures.

Authors:  W B Dobkowski; J M Murkin
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

9.  Development of a new arterial-line filter design using computational fluid dynamics analysis.

Authors:  Daniel P Herbst; Hani K Najm
Journal:  J Extra Corpor Technol       Date:  2012-09

10.  Microemboli from cardiopulmonary bypass are associated with a serum marker of brain injury.

Authors:  Robert C Groom; Reed D Quinn; Paul Lennon; Janine Welch; Robert S Kramer; Cathy S Ross; Peter A Beaulieu; Jeremiah R Brown; David J Malenka; Gerald T O'Connor; Donald S Likosky
Journal:  J Extra Corpor Technol       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.